These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18473966)

  • 21. BP180 gene delivery in junctional epidermolysis bullosa.
    Seitz CS; Giudice GJ; Balding SD; Marinkovich MP; Khavari PA
    Gene Ther; 1999 Jan; 6(1):42-7. PubMed ID: 10341874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells.
    Mavilio F; Pellegrini G; Ferrari S; Di Nunzio F; Di Iorio E; Recchia A; Maruggi G; Ferrari G; Provasi E; Bonini C; Capurro S; Conti A; Magnoni C; Giannetti A; De Luca M
    Nat Med; 2006 Dec; 12(12):1397-402. PubMed ID: 17115047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy of epidermolysis bullosa.
    Bauer JW; Laimer M
    Expert Opin Biol Ther; 2004 Sep; 4(9):1435-43. PubMed ID: 15335311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem Cell Therapy for Epidermolysis Bullosa-Does It Work?
    Tamai K; Uitto J
    J Invest Dermatol; 2016 Nov; 136(11):2119-2121. PubMed ID: 27772543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular basis for inherited bullous diseases.
    Korge BP; Krieg T
    J Mol Med (Berl); 1996 Feb; 74(2):59-70. PubMed ID: 8820401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The joint battle to tackle epidermolysis bullosa through gene therapy.
    De Rosa L; De Luca M
    Trends Mol Med; 2022 Jul; 28(7):533-535. PubMed ID: 35599142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
    Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
    Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermolysis bullosa: new and emerging trends.
    Pai S; Marinkovich MP
    Am J Clin Dermatol; 2002; 3(6):371-80. PubMed ID: 12113646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional therapies for cutaneous wound repair in epidermolysis bullosa.
    Peking P; Koller U; Murauer EM
    Adv Drug Deliv Rev; 2018 Apr; 129():330-343. PubMed ID: 29248480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
    Cutlar L; Greiser U; Wang W
    Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapies for inherited skin fragility disorders.
    Has C; Kiritsi D
    Exp Dermatol; 2015 May; 24(5):325-31. PubMed ID: 25916580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of tissue-targeting hemagglutinating virus of Japan envelope vector for successful delivery of therapeutic gene to mouse skin.
    Kawachi M; Tamai K; Saga K; Yamazaki T; Fujita H; Shimbo T; Kikuchi Y; Nimura K; Nishifuji K; Amagai M; Uitto J; Kaneda Y
    Hum Gene Ther; 2007 Oct; 18(10):881-94. PubMed ID: 17892442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow transplantation in epidermolysis bullosa.
    Abdul-Wahab A; Petrof G; McGrath JA
    Immunotherapy; 2012 Dec; 4(12):1859-67. PubMed ID: 23240753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inherited epidermolysis bullosa].
    Lykova SG; Maksimova YV; Nemchaninova OB; Guseva SN; Omigov VV; Aidagulova SV
    Arkh Patol; 2018; 80(4):54-60. PubMed ID: 30059072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inherited epidermolysis bullosa: past, present, and future.
    Fine JD
    Ann N Y Acad Sci; 2010 Apr; 1194():213-22. PubMed ID: 20536471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa.
    De Rosa L; Carulli S; Cocchiarella F; Quaglino D; Enzo E; Franchini E; Giannetti A; De Santis G; Recchia A; Pellegrini G; De Luca M
    Stem Cell Reports; 2014 Jan; 2(1):1-8. PubMed ID: 24511464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The genodermatoses: candidate diseases for gene therapy.
    Uitto J; Pulkkinen L
    Hum Gene Ther; 2000 Nov; 11(16):2267-75. PubMed ID: 11084685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translating the combination of gene therapy and tissue engineering for treating recessive dystrophic epidermolysis bullosa.
    Dakiw Piaceski A; Larouche D; Ghani K; Bisson F; Cortez Ghio S; Larochelle S; Moulin VJ; Caruso M; Germain L
    Eur Cell Mater; 2018 Feb; 35():73-86. PubMed ID: 29441510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa.
    De Rosa L; Enzo E; Zardi G; Bodemer C; Magnoni C; Schneider H; De Luca M
    Front Genet; 2021; 12():705019. PubMed ID: 34539738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular therapies for epidermolysis bullosa.
    Has C; Kiritsi D
    G Ital Dermatol Venereol; 2013 Feb; 148(1):65-72. PubMed ID: 23407078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.